Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-059960
Filing Date
2021-10-07
Accepted
2021-10-07 17:41:15
Documents
2
Period of Report
2021-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15501
2 EX-24 DOCUMENT attachment1.htm EX-24 3975
  Complete submission text file 0001209191-21-059960.txt   20874
Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Crowley John F (Reporting) CIK: 0001400973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 211313211

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances